NEW YORK (GenomeWeb) – The National Institutes of Health has awarded an approximately $2.8 million Phase IIB Small Business Innovation Research (SBIR) grant to microRNA diagnostics firm DiamiR.

The three-year grant from the National Institute on Aging will help the company develop its first test, CogniMir, CEO Kira Sheinerman said in a statement. The test is targeted at early-stage Alzheimer's disease patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.